Race Oncology (Race Oncology) Other Long-Term Liabilities : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Race Oncology Other Long-Term Liabilities?

Race Oncology's other long-term liabilities for the quarter that ended in Dec. 2023 was $0.00 Mil.

Race Oncology Other Long-Term Liabilities Historical Data

The historical data trend for Race Oncology's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Race Oncology Other Long-Term Liabilities Chart

Race Oncology Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Race Oncology Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial										-	-	-	-	-

Race Oncology Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Race Oncology Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Race Oncology's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Race Oncology (Race Oncology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Race Oncology Ltd (OTCPK:RAONF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

RAC:Australia

Address

1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000

Website

https://www.raceoncology.com

Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its product includes Bisantrene, a cancer chemotherapy drug. Its operating segments include research into oncology drugs, Zantrene and the manufacturing and distribution of the drug for clinical trials.

Race Oncology (Race Oncology) Headlines

From GuruFocus

Race executes global license agreement with City of Hope to access FTO IP

By PRNewswire • 07-10-2023

Race Strategic Update August 2023

By PRNewswire • 08-08-2023

Race executes agreement with Ardena for GMP manufacturing of RC220

By PRNewswire • 07-12-2023